SOUTNAKHON PHANDANOUVONG: Open Payments
NPI 1780273250 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,669 in 109 payments from 15 companies in 2025. Trend: 2023 $335 · 2024 $150 · 2025 $1,669
Food & beverage: $1,669
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $302 |
| Philips North America LLC | 17 | $278 |
| GlaxoSmithKline, LLC. | 26 | $257 |
| Viatris Specialty LLC | 11 | $171 |
| Regeneron Healthcare Solutions, Inc. | 11 | $145 |
| GENZYME CORPORATION | 10 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Verona Pharma, Inc. | 3 | $61 |
| Grifols USA, LLC | 2 | $48 |
Products named: DUPIXENT, Vest Therapy Und, YUPELRI, TEZSPIRE, TRELEGY ELLIPTA, NUCALA, BREZTRI, GLASSIA.
Industry payments across AR — which companies pay providers there.
